Deadline’s Read the Screenplay series spotlighting the scripts behind the awards season’s most talked-about movies continues with Warner Bros‘ Weapons. Writer-director Zach Cregger described the ...

This project is funded in part by the Gordon and Betty Moore Foundation through Grant GBMF10224, and the National Science Foundation under Grant GBMF10224 to the National Academy of Sciences. Any ...

Some of 2025’s scientific discoveries pushed the limits. Earth’s longest lightning and the first AI-generated genomes are among this year’s superlative achievements, along with black holes old and ...

Golden apple snails have eyes that are similar to humans’—and they can regenerate an amputated eye in just a month. Scientists uncovered a gene related to that process, laying the groundwork for more ...

A landmark real-world experiment gave the strongest evidence yet that the shingles vaccine could lower the risk of Alzheimer’s disease and other forms of dementia, finally giving concrete data to ...

For a spec screenwriter looking for a way into the studio system, few things are better than landing on The Black List. “Twenty-one years into this experiment, it still feels a little miraculous that ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min 67-year-old company plans move ...

In 1969, a now-iconic commercial first popped the question, “How many licks does it take to get to the Tootsie Roll center of a Tootsie Pop?” This deceptively simple line in a 30-second script managed ...

A statistical analysis found that the number of fake journal articles being churned out by “paper mills” is doubling every year and a half. By Carl Zimmer For years, whistle-blowers have warned that ...

Core Scientific, Inc. (NASDAQ:CORZ) is one of the top bitcoin mining stocks to buy amid bitcoin hike. On July 14, Citizens JMP downgraded Core Scientific, Inc. (NASDAQ:CORZ) to Market Perform from ...

Fintel reports that on July 14, 2025, JMP Securities downgraded their outlook for Core Scientific (NasdaqGS:CORZ) from Market Outperform to Market Perform. Analyst Price Forecast Suggests 47.48% ...